These discussions are already underway and have led to a new proposition about how to identify those with clinical need who would benefit most from these drugs, although this is not without controversy [62, 63]
[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Estes C., Anstee Q.M., Arias-Loste M.T., Bantel H., Bellentani S., Caballeria J., Colombo M., Craxi A., Crespo J., Day C.P., et al
Nothing about the dose size changes across phases in the documented protocol only the frequency changes

Federal vs State Regulations: Federal Rules Apply Everywhere: Semaglutide requires prescription from licensed provider Provider must conduct appropriate medical evaluation Pharmacies must be properly licensed and registered For compounded semaglutide: must be on FDA shortage list State Rules Vary: Telemedicine Prescribing: Some states allow prescribing after video/phone consultation only Others permit asynchronous (message-based) prescribing A few require initial in-person visit before telemedicine Provider must hold active license in patients state Pharmacy Regulations: Interstate pharmacy compacts allow some reciprocal licensing Some states require in-state pharmacy licensing to ship there Compounding regulations vary by state Some states have stricter oversight than others States with Fewest Restrictions: These states generally have more permissive telemedicine and compounding regulations: Texas Florida California Arizona Colorado Tennessee Georgia North Carolina Nevada Utah Most telehealth providers serve these states with minimal additional requirements

TPO is the "worker" that helps attach iodine to the protein scaffold that eventually becomes thyroid hormone
Ready, steady, go